Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study

British Journal of Ophthalmology

Volumn 93, Issue 7, 2009, Pages 914-919

  Schmid Kubista, K E ^a   Krebs, I ^a   Gruenberger, B ^a   Zeiler, F ^a   Schueller, J ^a   Binder, S ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; TREATMENT RESPONSE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; EPIDEMIOLOGIC METHODS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INFUSIONS, INTRAVENOUS; MACULAR DEGENERATION; MALE; TREATMENT OUTCOME;

EID: 67649639106     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.144410     Document Type: Article

References (25)

1. Age-Related Eye Disease Study Research Group. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 2003;121:1621-1624 (Pubitemid 37392370)
2. Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997;81:154-162 (Pubitemid 27092496)
3. Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 2002;22:143-152 (Pubitemid 36125089)
4. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003;110:979-986 (Pubitemid 36560500)
5. Michels S, Rosenfeld PJ. Ranibizumab therapy for neovascular age-related macular degeneration. Retin Physician 2004;1:34-36
6. Michels S, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Ophthalmology 2005;112:1035-1047
7. Tretament of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choriodal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 1999;117:1329-1345
8. VIP Study Group. Verteprofin therapy of subfoveal choriodal neovascularisation in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choriodal neovascularisation-verteprofin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560 (Pubitemid 32427660)
9. Krebs I, Binder S, Stolba U, et al. Reading ability and central visual field after photodynamic therapy. Ophthalmologica 2004;218:185-192 (Pubitemid 38596585)
10. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteprofin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003;110:1517-1525 (Pubitemid 36962483)
11. Rechtman E, Danis RP, Pratt LM, et al. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2004;88:344-347 (Pubitemid 38333711)
12. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularisation resulting from age-related macular degeneration: A pilot study. Am J Ophthalmol 2002;133:215-225 (Pubitemid 34072050)
13. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci 2004;45:4151-4160 (Pubitemid 39411174)
14. Thomas MA, Grand MG, Williams DF, et al. Surgical management of subfoveal choriodal neovascularisation. Ophthalmology 1992;99:952-968
15. Kabbinavar FF, Schulz J, McCleod M, et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized Phase II trial. J Clin Oncol 2005;23:3697-3705 (Pubitemid 46252464)
16. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New Engl J Med 2004;350:2335-2342 (Pubitemid 38702844)
17. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335 (Pubitemid 41073112)
18. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372 (Pubitemid 43296975)
19. Jonas JB, Libondi T, Ihloff AK, et al. Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type. Acta Ophthalmol Scand 2007;85:563-565 (Pubitemid 47163119)
20. Pedersen R, Soliman W, Lund-Andersen H, et al. Treatment of choroidal neovascularization using intravitreal bevacizumab. Acta Ophthalmol Scand 2007;85:526-533 (Pubitemid 47163114)
21. Lux A, Llacer H, Heussen FMA, et al. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophtahlmol 2007;91:1318-1322 (Pubitemid 47492865)
22. Cleary CA, Jungkim S, Ravikumar K, et al. Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-months results. Eye 2008;22:82-86
23. Madhusudhana KC, Hannan SR, Williams CPR, et al. Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases. Br J Ophthalmol 2007;91:1716-1717 (Pubitemid 350207411)
24. Radner W, Obermayer W, Richter-Mueksch S, et al. The validity and reliability of short German sentences for measuring reading speed. Graefes Arch Clin Exp Ophthalmol 2002;240:461-467 (Pubitemid 36097067)
25. Pauleikhoff D, Radermacher M, Spital G, et al. Visual prognosis of second eyes in patients with unilateral late exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2002;240:539-542 (Pubitemid 36097081)